$ARQ

Arq, Inc. (ARQ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Arq, Inc. (ARQ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex101arqinc2026omnibusince.htm EX-10.1 Document Exhibit 10.1 ARQ, INC. 2026 OMNIBUS INCENTIVE PLAN (Approved by stockholders on June 10, 2026) 1. ESTABLISHMENT, OBJECTIVES AND DURATION. (a) Establishment of the Plan . Arq, Inc. hereby establishes an incentive compensati

Original reporting
Published Jun 11, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ARQ
Neutral
medium confidence
Mentioned
$ARQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARQNeutralLow
01

Why it matters

The plan authorizes multiple equity and cash award types and sets limits (e.g., maximum shares available for grants and minimum vesting requirements), which can influence future dilution and incentive structure.

02

Market read

Primarily governance/compensation mechanics; potential indirect dilution/incentive implications, but no new financial targets or operational catalysts are disclosed in the provided text.

03

What to watch

Traders may want to check whether the plan’s share pool meaningfully increases potential dilution versus prior plans, and whether any concurrent director/officer changes were disclosed elsewhere in the 8-K (not included in the excerpt).

Relevance 6/10Novelty 4/10Timing: Filed after-hours/late day (2026-06-11 16:31 ET)

Background

The filing is an SEC 8-K (Item 5.02/5.07) describing director/officer matters and attaching the company’s 2026 Omnibus Incentive Plan approved by stockholders on June 10, 2026.

Company-level read

Ticker impact

$ARQNeutralMedium confidence
Context

Arq, Inc. filed an 8-K approving its 2026 Omnibus Incentive Plan and related director/officer compensation arrangements.

Expected impact

Likely limited near-term price impact; any effect would be indirect via expectations for hiring/retention and potential dilution from future equity grants.

Evidence & confidence

The disclosure is an incentive plan framework (share pool, award types, vesting/minimums) rather than new earnings, contracts, or regulatory outcomes.

Market effects

Minimal—compensation-plan filings are company-specific and don’t signal sector-wide demand or regulation changes in the provided text.

None indicated.

None indicated.

Counterpoint

The share pool size and award flexibility could matter more than usual if the company is preparing for a hiring/turnaround cycle, but the filing text doesn’t specify grant amounts or timing.

Key entities

  • Arq, Inc.

    Company adopting the 2026 Omnibus Incentive Plan and related compensatory arrangements for directors/officers.

  • 2026 Omnibus Incentive Plan

    Framework for granting options, RSUs, performance stock units, and other stock-based/cash-based awards; effective June 10, 2026 subject to stockholder approval.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.